Sign inGet started

EBERT CHARLES D

Insider CIK 1241752 · ACT SVP, BRANDS R&D · WPI Sr. VP, Research & Development

Track record PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/yearAlready Pro? Log in

Trades across companies

TickerCodeTradeFiledSharesPriceValueOwned after
ACT Actavis plc S Sale2013-11-062013-11-0810,877$158.75 $1.73M7,611SEC↗
ACT Actavis, Inc. D To issuer2013-10-012013-10-0218,488— $00SEC↗
ACT Actavis plc A Award2013-10-012013-10-0318,488— $018,488SEC↗
ACT Actavis, Inc. A Award2013-09-302013-10-0212,212— $032,182SEC↗
ACT Actavis, Inc. F Tax w/h2013-09-302013-10-0213,694$144.00 $1.97M18,488SEC↗
ACT Actavis, Inc. F Tax w/h2013-08-052013-08-068,244$136.25 $1.12M19,970SEC↗
ACT Actavis, Inc. S Sale2013-08-052013-08-138,244$136.25 $1.12M19,970SEC↗
ACT Actavis, Inc. A Award2013-03-062013-03-082,653— $026,487SEC↗
ACT Actavis, Inc. A Award2013-03-062013-03-081,727— $028,214SEC↗
ACT Actavis, Inc. F Tax w/h2013-03-052013-03-071,331$86.46 $115.1K23,834SEC↗
ACT Actavis, Inc. F Tax w/h2013-03-022013-03-051,761$85.54 $150.6K25,165SEC↗
WPI WATSON PHARMACEUTICALS INC F Tax w/h2012-03-142012-03-161,265$59.21 $74.9K26,926SEC↗
WPI WATSON PHARMACEUTICALS INC A Award2012-03-082012-03-123,342— $025,625SEC↗
WPI WATSON PHARMACEUTICALS INC A Award2012-03-082012-03-122,566— $028,191SEC↗
WPI WATSON PHARMACEUTICALS INC M Exercise deriv2012-02-292012-03-011,000— $00SEC↗
WPI WATSON PHARMACEUTICALS INC M Exercise2012-02-292012-03-011,000$25.64 $25.6K27,264SEC↗
WPI WATSON PHARMACEUTICALS INC S Sale2012-02-292012-03-013,981$58.81 $234.1K22,283SEC↗
WPI WATSON PHARMACEUTICALS INC S Sale2012-02-292012-03-011,000$58.77 $58.8K26,264SEC↗
WPI WATSON PHARMACEUTICALS INC F Tax w/h2012-02-242012-02-281,458$58.17 $84.8K26,264SEC↗